User menu

The clinical benefit of eculizumab is demonstrable in all subpopulations of patients with paroxysmal nocturnal hemoglobinuria (PNH) with hemolysis

Bibliographic reference Muus, P. ; Van Den Neste, Eric ; Duehrsen, U. ; Elebute, M. ; Browne, P. ; et. al. The clinical benefit of eculizumab is demonstrable in all subpopulations of patients with paroxysmal nocturnal hemoglobinuria (PNH) with hemolysis.12th Congress of the European-Hematology-Association (Vienna (Austria), Jun 07-10, 2007). In: Haematologica : the hematology journal, Vol. 92, p. 137-138 (2007)
Permanent URL http://hdl.handle.net/2078.1/59610